Efficacy and Safety of Luspatercept in Patients Enrolled in the BELIEVE Trial: Data from the Phase 3b Long-Term Rollover Study

被引：2

作者：

Cappellini, Maria Domenica ^{[1
]}

Taher, Ali T. ^{[2
]}

Viprakasit, Vip ^{[3
]}

Georgiev, Pencho ^{[4
]}

Kuo, Kevin H. M. ^{[5
,6
]}

Holot, Natalia ^{[7
]}

Vilmont, Valerie ^{[8
]}

Medlin, Loyse Felber ^{[8
]}

Kuo, Wen-Ling ^{[7
]}

Lai, Yinzhi ^{[7
]}

Bueno, Luciana Moro ^{[8
]}

Sheth, Sujit ^{[9
]}

机构：

[1] Univ Milan, Fdn IRCCS Ca Granda Policlin Hosp, Milan, Italy

[2] Amer Univ, Dept Internal Med, Beirut Med Ctr, Beirut, Lebanon

[3] Mahidol Univ, Siriraj Res Hosp, Bangkok, Thailand

[4] Med Univ Plovdiv, Plovdiv, Bulgaria

[5] Univ Hlth Network, Div Med Oncol & Hematol, Dept Med, Toronto, ON, Canada

[6] Univ Toronto, Div Hematol, Dept Med, Toronto, ON, Canada

[7] Bristol Myers Squibb, Princeton, NJ USA

[8] Bristol Myers Squibb Co, Celgene Int Sarl, Boudry, Switzerland

[9] Weill Cornell Med, Div Pediat Hematol Oncol, New York, NY USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-174089

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[21] BIMEKIZUMAB LONG-TERM SAFETY AND EFFICACY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A PHASE 2B STUDY
Van der Heijde, D.
Deodhar, A.
Gensler, L. S.
Poddubnyy, D.
Kivitz, A.
Dougados, M.
De Peyrecave, N.
Oortgiesen, M.
Vaux, T.
Fleurinck, C.
Baraliakos, X.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 332 - 333
[22] Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study
Platzbecker, Uwe
Goetze, Katharina S.
Kiewe, Philipp
Germing, Ulrich
Mayer, Karin
Radsak, Markus
Wolff, Thomas
Chromik, Joerg
Sockel, Katja
Oelschlaegel, Uta
Haase, Detlef
Illmer, Thomas
Al-Ali, Haifa Kathrin
Silling, Gerda
Reynolds, Joseph G.
Zhang, Xiaosha
Attie, Kenneth M.
Shetty, Jeevan K.
Giagounidis, Aristoteles
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (33) : 3800 - +
[23] Efficacy, safety, and tolerability of remibrutinib (LOU064) in CSU patients: Study design of phase 3B extension trial
Maurer, M.
Gimenez-Arnau, A. M.
Saini, S.
Lebwohl, M.
Sussman, G.
Hide, M.
Lheritier, K.
Zharkov, A.
Bhat, S.
Wei, L.
Martzloff, E. D.
Haemmerle, S.
ALLERGY, 2023, 78
[24] Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901
Manns, Michael P.
Akarca, Ulus S.
Chang, Ting-Tsung
Sievert, William
Yoon, Seung Kew
Tsai, Naoky
Min, Albert
Pangerl, Andreas
Beebe, Suzanne
Yu, Miao
Wongcharatrawee, Suchat
EXPERT OPINION ON DRUG SAFETY, 2012, 11 (03) : 361 - 368
[25] Efficacy and Safety of Linaclotide in Chronic Idiopathic Constipation Patients With Abdominal Bloating: Phase 3b Trial Results
Lacy, Brian E.
Lembo, Anthony
Schey, Ron
Lavins, Bernard J.
Eng, Paul F.
Fox, Susan M.
Jia, Xinwei D.
Hao, Xinming
Currie, Mark G.
Kurtz, Caroline B.
Johnston, Jeffrey
Shiff, Steven J.
GASTROENTEROLOGY, 2014, 146 (05) : S353 - S353
[26] Long-Term Efficacy and Safety Results From a Phase II Study of Ruxolitinib in Patients with Polycythemia Vera
Verstovsek, Srdan
Passamonti, Francesco
Rambaldi, Alessandro
Barosi, Giovanni
Rosen, Peter J.
He, Shui
Contel, Nancy
Mookerjee, Bijoyesh
Rumi, Elisa
Gattoni, Elisabetta
Pieri, Lisa
Cazzola, Mario
Kantarjian, Hagop M.
Barbui, Tiziano
Vannucchi, Alessandro M.
BLOOD, 2012, 120 (21)
[27] Long-term efficacy and safety of idebenone in patients with LHON in the chronic phase: Results from the LEROS study
Lloria, Xavier
Tomasso, Livia
Klopstock, Thomas
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
[28] Long-term safety and efficacy of adalimumab from the phase 3 randomized placebo-controlled trial in patients with nail and skin psoriasis
Crowley, Jeff
Gisondi, Paolo
Geng, Ziqian
Servin, Ofelia Reyes
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB181 - AB181
[29] LONG-TERM SAFETY AND EFFICACY OF ADALIMUMAB FROM THE PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN PATIENTS WITH NAIL AND SKIN PSORIASIS
Crowley, Jeff
Gisondi, Paolo
Geng, Ziqian
Servin, Ofelia Reyes
ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 25 - 25
[30] LONG-TERM SAFETY AND EFFICACY OF ACOTIAMIDE IN PATIENTS WITH FUNCTIONAL DYSPEPSIA (POSTPRANDIAL DISTRESS SYNDROME) - RESULTS FROM THE EUROPEAN PHASE 3 TRIAL
Tack, Jan F.
Pokrotnieks, Juris
Urbonas, Gediminas
Banciu, Christian
Yakusevich, Vladimir
Bunganic, Ivan
Tornblom, Hans
Kleban, Yaroslav
Eavis, Patrick
Tsuchikawa, Masaru
Miyagawa, Tomoharu
GASTROENTEROLOGY, 2018, 154 (06) : S554 - S554

← 1 2 3 4 5 →